enzalutamide
Showing 1 - 25 of 145
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Metastatic Prostate Cancer Trial in Toronto (Enzalutamide, Standard of Care SBRT and ADT)
Not yet recruiting
- Metastatic Prostate Cancer
- Enzalutamide
- Standard of Care SBRT and ADT
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Center
May 30, 2022
Cancer of the Prostate, Prostate Cancer Trial in Switzerland (Enzalutamide, Metformin)
Active, not recruiting
- Cancer of the Prostate
- Prostate Cancer
- Enzalutamide
- Metformin
-
Aarau, Switzerland
- +15 more
Jun 9, 2022
COVID-19 Infection Trial in Bellinzona (Enzalutamide)
Terminated
- COVID-19 Infection
- Enzalutamide
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland (IOSI)
Aug 7, 2022
Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)
Not yet recruiting
- Metastatic Cancer
- Neoplasm, Prostate
- Abiraterone acetate
- +2 more
-
Bronx, New YorkJames J. Peters VA Medical Center
Jun 16, 2022
Prostate Cancer Trial in Chisinau (enzalutamide, enzalutamide Placebo, digoxin)
Completed
- Prostate Cancer
- enzalutamide
- +3 more
-
Chisinau, Moldova, Republic ofSite MD37301
Jan 14, 2022
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco (FOR46, Enzalutamide, Pegfilgrastim)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- FOR46
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 1, 2022
Called DEAR, to Learn More About Treatment With Darolutamide,
Active, not recruiting
- Non-metastatic Castration-resistant Prostate Cancer
- Darolutamide (Nubeqa, BAY1841788)
- +2 more
-
Whippany, New JerseyBayer
Jul 29, 2022
Prostate Cancer Trial in Sacramento (Enzalutamide, Metformin Hydrochloride)
Active, not recruiting
- Prostate Cancer
- Enzalutamide
- Metformin Hydrochloride
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jan 11, 2022
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Enzalutamide,
Active, not recruiting
- Metastatic Prostate Carcinoma
- +2 more
- Enzalutamide
- Niclosamide
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Feb 23, 2022
Prostate Cancer Trial in Boston (Tivozanib, Enzalutamide)
Active, not recruiting
- Prostate Cancer
- Tivozanib
- Enzalutamide
-
Boston, MassachusettsMassachusetts General Hospital
Oct 25, 2021
Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore
Recruiting
- Prostate Cancer
- +2 more
- Testosterone Undecanoate
- Enzalutamide
-
Baltimore, MarylandJohns Hopkins Hospital
May 6, 2022
Castration-resistant Prostate Cancer Trial in Boston (Crizotinib, Enzalutamide)
Completed
- Castration-resistant Prostate Cancer
- Crizotinib
- Enzalutamide
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 5, 2022
Prostate Cancer Trial in Washington, Chicago, Baltimore (Enzalutamide, LY2157299)
Recruiting
- Prostate Cancer
- Enzalutamide
- LY2157299
-
Washington, District of Columbia
- +3 more
Jun 1, 2022
Prostate Cancer Trial in Japan (Enzalutamide)
Completed
- Prostate Cancer
- Enzalutamide
-
Kita-gun, Kagawa-prefecture, Japan
- +3 more
May 24, 2022
Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 18-FDG PET/CT, Whole body MRI)
Completed
- Prostate Cancer Metastatic
- Enzalutamide
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 6, 2022
Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 11C or 18F-Choline PET/CT, Whole body MRI)
Completed
- Prostate Cancer Metastatic
- Enzalutamide
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 6, 2022
Prostate Cancer, Bone Metastases Trial in Brescia (Zoledronic Acid, Enzalutamide)
Recruiting
- Prostate Cancer
- Bone Metastases
- Zoledronic Acid
- Enzalutamide
-
Brescia, ItalyAzienda Ospedaliera Spedali Civili di Brescia
Mar 4, 2022
Prostate Cancer, Prostatic Cancer, Cancer of Prostate Trial (NUV-422, Enzalutamide)
Not yet recruiting
- Prostate Cancer
- +7 more
- NUV-422
- Enzalutamide
- (no location specified)
Jan 12, 2022
Prostatic Tumors, Castration-Resistant Trial in Leiden (Patient-specific adaptive therapy, Abiraterone acetate, Enzalutamide)
Not yet recruiting
- Prostatic Neoplasms, Castration-Resistant
- Patient-specific adaptive therapy
- +2 more
-
Leiden, Zuid-Holland, NetherlandsLeids Universitair Medisch Centrum
May 23, 2022
Prostatic Tumors, Castration-Resistant Trial in New York (TVB-2640, Enzalutamide)
Not yet recruiting
- Prostatic Neoplasms, Castration-Resistant
- TVB-2640
- Enzalutamide
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Feb 23, 2023
Prostatic Tumors, Pelvic Nodal Trial in San Francisco (Enzalutamide, Leuprolide, Intensity-Modulated Radiation Therapy)
Terminated
- Prostatic Neoplasms
- Pelvic Nodal
- Enzalutamide
- +2 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Sep 14, 2021
Prostate Cancer, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide, CC-115)
Active, not recruiting
- Prostate Cancer
- Castration Resistant Prostate Cancer
- Enzalutamide
- CC-115
-
San Francisco, California
- +4 more
Mar 18, 2022